| Christina Lynn Malekiani, MD | |
|
2800 S Shirlington Rd, Ste 500, Arlington, VA 22206-3601 | |
| (703) 717-4245 | |
| (703) 717-4248 |
| Full Name | Christina Lynn Malekiani |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 19 Years |
| Location | 2800 S Shirlington Rd, Arlington, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790845790 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 0101240448 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginia Hospital Center | Arlington, VA | Hospital |
| Inova Alexandria Hospital | Alexandria, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Hospital Center Physician Group Llc | 8426231119 | 241 |
News Archive
Curasan AG, a leading specialist for medical products in the field of orthobiologics, has received the market clearance of the Food and Drug Administration (FDA) and thus the authorization to market its synthetic bone regeneration material CERASORB Ortho FOAM in the United States.
Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today a partnership agreement with Medical Education Technologies, Inc., a leading manufacturer of medical simulation and health care learning technologies.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it received FDA Fast Track designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients suffer from the progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.
A novel study published in Restorative Neurology and Neuroscience provides the first evidence that a simple and inexpensive non-invasive speech-to-touch sensory substitution device has the potential to improve hearing in hearing-impaired cochlear implant patients, as well as individuals with normal hearing, to better discern speech in various situations like learning a second language or trying to deal with the "cocktail party effect."
3M and MicroDose Technologies Inc., a privately held drug delivery company based in Monmouth Junction, N.J., announced today that the two companies have entered into an exclusive co-development and joint marketing agreement.
› Verified 3 days ago
| Entity Name | Virginia Hospital Center Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144415480 PECOS PAC ID: 8426231119 Enrollment ID: O20110317000305 |
News Archive
Curasan AG, a leading specialist for medical products in the field of orthobiologics, has received the market clearance of the Food and Drug Administration (FDA) and thus the authorization to market its synthetic bone regeneration material CERASORB Ortho FOAM in the United States.
Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today a partnership agreement with Medical Education Technologies, Inc., a leading manufacturer of medical simulation and health care learning technologies.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it received FDA Fast Track designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients suffer from the progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.
A novel study published in Restorative Neurology and Neuroscience provides the first evidence that a simple and inexpensive non-invasive speech-to-touch sensory substitution device has the potential to improve hearing in hearing-impaired cochlear implant patients, as well as individuals with normal hearing, to better discern speech in various situations like learning a second language or trying to deal with the "cocktail party effect."
3M and MicroDose Technologies Inc., a privately held drug delivery company based in Monmouth Junction, N.J., announced today that the two companies have entered into an exclusive co-development and joint marketing agreement.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christina Lynn Malekiani, MD 2800 S Shirlington Rd, Ste 500, Arlington, VA 22206-3601 Ph: (703) 717-4245 | Christina Lynn Malekiani, MD 2800 S Shirlington Rd, Ste 500, Arlington, VA 22206-3601 Ph: (703) 717-4245 |
News Archive
Curasan AG, a leading specialist for medical products in the field of orthobiologics, has received the market clearance of the Food and Drug Administration (FDA) and thus the authorization to market its synthetic bone regeneration material CERASORB Ortho FOAM in the United States.
Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today a partnership agreement with Medical Education Technologies, Inc., a leading manufacturer of medical simulation and health care learning technologies.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it received FDA Fast Track designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients suffer from the progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.
A novel study published in Restorative Neurology and Neuroscience provides the first evidence that a simple and inexpensive non-invasive speech-to-touch sensory substitution device has the potential to improve hearing in hearing-impaired cochlear implant patients, as well as individuals with normal hearing, to better discern speech in various situations like learning a second language or trying to deal with the "cocktail party effect."
3M and MicroDose Technologies Inc., a privately held drug delivery company based in Monmouth Junction, N.J., announced today that the two companies have entered into an exclusive co-development and joint marketing agreement.
› Verified 3 days ago
Dr. Alvaro Andres Puig Rodriguez, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr Ste 425, Arlington, VA 22205 Phone: 703-717-4400 | |
Tiffany C Turner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr Ste 345, Arlington, VA 22205 Phone: 703-717-4400 Fax: 703-717-4401 | |
Dr. Anne Ruggles Pariser, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2921 11th St S, Arlington, VA 22204 Phone: 703-979-1400 | |
Dr. Michael Andrew Cole, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr, Intensive Care Unit, Arlington, VA 22205 Phone: 571-244-8410 | |
Robert Paul Holman, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1635 N George Mason Dr, Suite 180, Arlington, VA 22205 Phone: 703-276-7798 Fax: 703-276-0433 | |
Dr. Irmindra S Rana, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd, Suite 301, Arlington, VA 22204 Phone: 703-998-0480 Fax: 703-379-0449 | |
Dr. Ashok Chauhan, M.D., Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd, Suite 511, Arlington, VA 22204 Phone: 703-379-4446 Fax: 703-379-0449 |